{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:49:17Z","timestamp":1791510557694,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["UF-QN-202002"],"award-info":[{"award-number":["UF-QN-202002"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002979","name":"Dalian Institute of Chemical Physics, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012465","name":"Dalian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.numecd.2026.104768","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:33:56Z","timestamp":1776494036000},"page":"104768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcomes and safety profile of early low-density lipoprotein cholesterol target attainment in patients with atherosclerotic cerebral infarction: a prospective cohort study"],"prefix":"10.1016","volume":"36","author":[{"given":"Peixue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6615-6011","authenticated-orcid":false,"given":"Yongzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2026.104768_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jad.2018.11.086","article-title":"Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice","volume":"245","author":"Yu","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.numecd.2026.104768_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.numecd.2026.104768_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104768_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104768_bib5","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Se","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104768_bib6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104768_bib7","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in Statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104768_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.2018.2444","article-title":"Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI randomized clinical trial","volume":"319","author":"Berwanger","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104768_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11883-013-0360-6","article-title":"Update on lipoprotein(a) as a cardiovascular risk factor and mediator","volume":"15","author":"Boffa","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.numecd.2026.104768_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yjmcc.2021.02.004","article-title":"Lipoprotein compartmentalisation as a regulator of PCSK9 activity","volume":"155","author":"Burnap","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.numecd.2026.104768_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.amjcard.2014.05.060","article-title":"Effect of alirocumab, a monoclonal proprotein convertase subtilisin\/kexin 9 antibody, on lipoprotein(a) concentrations (A pooled analysis of 150 mg every two weeks dosing from phase 2 trials)","volume":"114","author":"Gaudet","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2026.104768_bib12","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.4030","article-title":"Effect of evolocumab or ezetimibe added to moderate- or high-intensity Statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial","volume":"311","author":"Robinson","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2026.104768_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104768_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101068","article-title":"Emerging roles of lysophospholipids in health and disease","volume":"80","author":"Tan","year":"2020","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.numecd.2026.104768_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MOL.0000000000000890","article-title":"The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis","volume":"34","author":"Chattopadhyay","year":"2023","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.numecd.2026.104768_bib16","article-title":"Phosphatidylethanolamine N-methyltransferase: from functions to diseases","volume":"14","author":"J","year":"2023","journal-title":"Aging Dis"},{"key":"10.1016\/j.numecd.2026.104768_bib17","article-title":"Sphingolipids contribute to human atherosclerotic plaque inflammation","volume":"36","author":"A","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2026.104768_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.plipres.2017.05.001","article-title":"HDL abnormalities in familial hypercholesterolemia: focus on biological functions","volume":"67","author":"Ganjali","year":"2017","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.numecd.2026.104768_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0955-2863(01)00181-4","article-title":"Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions","volume":"12","author":"Kummerow","year":"2001","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.numecd.2026.104768_bib20","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"M","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104768_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1194\/jlr.RA119000382","article-title":"Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation","volume":"61","author":"Kumar","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2026.104768_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/HYPERTENSIONAHA.119.14507","article-title":"Endothelial sphingolipid de novo synthesis controls blood pressure by regulating signal transduction and NO via ceramide","volume":"75","author":"Cantalupo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2026.104768_bib23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2026.104768_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008552","article-title":"Compounding benefits of cholesterol-lowering therapy for the reduction of major cardiovascular events: systematic review and meta-analysis","volume":"15","author":"Wang","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.numecd.2026.104768_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104768_bib26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.121.319994","article-title":"Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke","volume":"130","author":"Endres","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2026.104768_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12944-020-01270-2","article-title":"Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients","volume":"19","author":"Poupore","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2026.104768_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.778740","article-title":"Cerebrovascular disease and statins","volume":"8","author":"Beltr\u00e1n Romero","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2026.104768_bib29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12975-019-00750-7","article-title":"Statin therapy in ischemic stroke models: a meta-analysis","volume":"11","author":"Christophe","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.numecd.2026.104768_bib30","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2026.104768_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and cholesterol risk in the FOURIER trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104768_bib32","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104768_bib33","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis society consensus panel","volume":"38","author":"Ba","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104768_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2016.10.044","article-title":"Endothelial function and arterial stiffness indexes in subjects with acute ischemic stroke: relationship with TOAST subtype","volume":"256","author":"Tuttolomondo","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2026.104768_bib35","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104768_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/ATVBAHA.119.313200","article-title":"TLR4 (Toll-Like receptor 4)-Dependent signaling drives extracellular catabolism of LDL (Low-Density lipoprotein) aggregates","volume":"40","author":"Singh","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2026.104768_bib37","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"A","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.numecd.2026.104768_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245797","article-title":"Aggregated LDL turn human macrophages into foam cells and induce mitochondrial dysfunction without triggering oxidative or endoplasmic reticulum stress","volume":"16","author":"Sanda","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2026.104768_bib39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.numecd.2026.104768_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2026.104768_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41569-024-01100-3","article-title":"Cholesterol crystals in the pathogenesis of atherosclerosis","volume":"22","author":"Baumer","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2026.104768_bib42","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.numecd.2026.104768_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.04.010","article-title":"IL-2R\u03b2\u03b3 signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice","volume":"326","author":"Mulholland","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2026.104768_bib44","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1111\/bph.13845","article-title":"Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges","volume":"174","author":"Kyaw","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.numecd.2026.104768_bib45","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1189731","article-title":"ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation","volume":"328","author":"Yvan-Charvet","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.numecd.2026.104768_bib46","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2026.104768_bib47","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2026.104768_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2026.104768_bib49","doi-asserted-by":"crossref","first-page":"III27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104768_bib50","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104768_bib51","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Pm","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:02:14Z","timestamp":1788591734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326002309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0939475326002309"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104768","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes and safety profile of early low-density lipoprotein cholesterol target attainment in patients with atherosclerotic cerebral infarction: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104768"}}